GE HealthCare Technologies Share Holder Equity 2020-2024 | GEHC
GE HealthCare Technologies share holder equity from 2020 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- GE HealthCare Technologies share holder equity for the quarter ending March 31, 2024 was $7.423B, a 10.86% increase year-over-year.
- GE HealthCare Technologies share holder equity for 2023 was $7.145B, a 23.68% decline from 2022.
- GE HealthCare Technologies share holder equity for 2022 was $9.362B, a 43.86% decline from 2021.
- GE HealthCare Technologies share holder equity for 2021 was $16.676B, a 13.05% increase from 2020.
| GE HealthCare Technologies Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $7,145 |
| 2022 | $9,362 |
| 2021 | $16,676 |
| 2020 | $14,751 |
| 2019 | $0 |
| GE HealthCare Technologies Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-03-31 | $7,423 |
| 2023-12-31 | $7,145 |
| 2023-09-30 | $7,142 |
| 2023-06-30 | $7,114 |
| 2023-03-31 | $6,696 |
| 2022-12-31 | $9,362 |
| 2022-09-30 | $16,878 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | |
| 2021-09-30 | $0 |
| 2020-12-31 | $14,751 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $36.211B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $4.600B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.400B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.976B | 0.00 |
| Enovis (ENOV) | United States | $2.744B | 20.34 |
| IRhythm Technologies (IRTC) | United States | $2.738B | 0.00 |
| 10x Genomics (TXG) | United States | $2.735B | 0.00 |
| Azenta (AZTA) | United States | $2.710B | 152.33 |
| Privia Health (PRVA) | United States | $1.922B | 107.40 |
| Schrodinger (SDGR) | United States | $1.586B | 0.00 |
| Omnicell (OMCL) | United States | $1.456B | 50.32 |
| Phreesia (PHR) | United States | $1.287B | 0.00 |
| Standard BioTools (LAB) | United States | $0.965B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.659B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.633B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.491B | 0.00 |
| Talkspace (TALK) | United States | $0.470B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
| Pulmonx (LUNG) | United States | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.310B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| Outset Medical (OM) | United States | $0.206B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.190B | 0.00 |
| TruBridge (TBRG) | United States | $0.147B | 7.88 |
| American Well (AMWL) | United States | $0.135B | 0.00 |
| 111 (YI) | China | $0.104B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.099B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| HeartBeam (BEAT) | United States | $0.071B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| Augmedix (AUGX) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| CareCloud (CCLD) | United States | $0.043B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |